-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
The new study shows that the brain damage that type 1 diabetes causes to adolescents is reversible
.
Researchers from Stanford University School of Medicine and the Nemoor Children's Health Center in Jacksonville collaborated to lead the proof-of-concept pilot study, the most thorough investigation
on the topic to date.
"These results offer hope for the damage that type 1 diabetes can do to the developing brain, which may be reversible with strict glucose control," said Nelly Mauras, MD, a pediatric endocrinologist at the Nemol Children's Health Center in Jacksonville and a professor of pediatrics at
the Mayo Clinical School of Medicine, senior author and co-lead investigator of the paper.
The study was conducted
through the Five Centers Pediatric Diabetes Research Network (DirecNet).
Dr.
Mixing a closed-loop insulin delivery system, when used properly and continuously, can increase blood sugar in a healthy range of time
.
Participants who used closed-loop glucose control systems showed significantly greater improvements in key brain indicators that reflected normal teen brain development than the standard care group — in other words, their results were closer to those of adolescents
without diabetes.
"We have long known that better control of blood sugar levels in people with type 1 diabetes can prevent or reduce damage to some biological systems (e.
Type 1 diabetes is an autoimmune disease in which a patient's immune system mistakenly destroys insulin-producing cells
in the pancreas.
A Pilot randomized trial to examine effects of a hybrid closed-loop insulin delivery system on neurodevelopmental and cognitive outcomes in adolescents with type 1 diabetes